Search clinical trials for: Peptic ulcer rebleeding, double dose of esomeprazole

Total 430780 results

National Cheng-Kung University Hospital
National Science Council, Taiwan

Completed

The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers (DDE)

Peptic Ulcer Bleeding

Taiwan
Xijing Hospital of Digestive Diseases

Recruiting

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Gastritis | Dyspepsia | Gastric Cancer | Peptic Ulcer | Helicobacter Pylori Infection

China
Xijing Hospital of Digestive Diseases

Enrolling by invitation

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Gastritis | Dyspepsia | Gastric Cancer | Peptic Ulcer | Helicobacter Pylori Infection

China
Changhua Christian Hospital
Taipei Medical University Hospital; Dalin Tzu Chi General Hospital

Withdrawn

Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy (lowdosePPI)

Peptic Ulcer Bleeding

Taiwan
Yonsei University

Completed

Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial

Chronic Cough Caused by Gastroesophageal Reflux

Korea, Republic of
National Cheng-Kung University Hospital

Unknown

Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis

Gastroesophageal Reflux Disease
AstraZeneca

Completed

High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

Bleeding Peptic Ulcer

China
Shanghai Jiao Tong University School of Medicine

Completed

Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori

Functional Dyspepsia | Peptic Ulcer | Helicobacter Pylori

China
AstraZeneca

Completed

Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

Prevention

Korea, Republic of, Japan, Taiwan
AstraZeneca

Completed

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) (NEON)

Gastroesophageal Reflux Disease

Chile, Argentina, Venezuela, Colombia
AstraZeneca

Completed

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (Oberon)

Gastric Ulcer | Duodenal Ulcer

United States, Bulgaria, Czech Republic, Korea, Republic of, Russian Federation, South Africa, Philippines, Poland, Romania, Finland, Norway, Canada, Mexico, Argentina, Australia, Germany, Portugal, Slovakia, Thailand, Indonesia
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Taipei Medical University

Unknown

A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

Upper Gastrointestinal Bleeding

Taiwan
Chinese University of Hong Kong

Completed

Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

Gastroesophageal Reflux Disease

China
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Symptomatic Gastroesophageal Reflux Disease (sGERD)
Yongquan Shi

Recruiting

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer

China
Alexandria University

Recruiting

Vonoprazan for Helicobacter Pylori Eradication in Adolescents (VONTAPE)

Treatment Effectiveness

Egypt
Shandong University
Zibo Central Hospital; Peking University Care Luzhong Hospital; Taierzhuang District... and other collaborators

Recruiting

Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Helicobacter Pylori Infection

China
West China Hospital

Not yet recruiting

Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

Upper Gastrointestinal Hemorrhage
Xuanzhu Biopharmaceutical Co., Ltd.

Not yet recruiting

Drug-drug Interaction Study of XZP-3621 Tablet

Healthy Subjects

China
Chinese University of Hong Kong
Nanfang Hospital, Southern Medical University

Recruiting

PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers

Proton Pump Inhibitors | Upper GI Bleeding

China
RenJi Hospital

Recruiting

Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.

Gastric Cancer | Intestinal Polyps | Gastric Ulcer | Intestinal Cancer

China
Shandong University
Zibo Central Hospital; Peking University Care Luzhong Hospital; Yuncheng Traditional... and other collaborators

Not yet recruiting

Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

Helicobacter Pylori Infection
Oncogastroenterology Committee of Chinese
First Affiliated Hospital Xi'an Jiaotong University; Henan Provincial People... and other collaborators

Not yet recruiting

Clinical Trial of Reconstruction After Proximal Gastrectomy

Esophagitis, Reflux
Prof Urs Zingg

Recruiting

The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

Obesity | Ulcer, Gastric | Gastric Reflux

Switzerland
Hospital da Senhora da Oliveira

Recruiting

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Gastritis | Gastric Cancer | Helicobacter Pylori Infection

Portugal
wang xiaoyan

Recruiting

Differences in the Eradication of Helicobacter Pylori by Different Therapies

Helicobacter Pylori Infection

China
Universitätsklinikum Hamburg-Eppendorf
German Federal Ministry of Education and Research; University Hospital Heidelberg

Recruiting

Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial (STOPPIT)

Liver Cirrhosis

Germany
Chinese University of Hong Kong
National Taiwan University Hospital; Beijing Friendship Hospital

Recruiting

When Should Low-dose Aspirin be Resumed After Peptic Ulcer Bleeding?

Aspirin | GastroIntestinal Bleeding

Hong Kong
Alimentiv Inc.

Active, not recruiting

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis (PROTOS)

Ulcerative Colitis

United States, Canada
The Third Xiangya Hospital of Central South University
The Second People's Hospital of Huaihua; Yueyang Hospital of Traditional Chinese...

Completed

Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Shandong University
Zibo Central Hospital; Peking University Care Luzhong Hospital; Yuncheng Traditional... and other collaborators

Completed

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

Helicobacter Pylori Infection

China
Cinclus Pharma AG
Parexel

Completed

A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole

Erosive Esophagitis

Poland, Bulgaria, Serbia, Georgia, United States, Czechia, Hungary, Ukraine
Insmed Incorporated

Completed

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

Healthy Volunteers

United States
Eisai Co., Ltd.

Completed

A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

Gastroesophageal Reflux Disease

Japan
Livzon Pharmaceutical Group Inc.

Completed

A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding

Stress Ulcer Bleeding

China
AstraZeneca

Completed

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

Gastric Ulcer | Duodenal Ulcer | Reflux Esophagitis

Japan
Young-Hak Kim, MD, PhD

Completed

Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (DAPTALBIS)

Gastritis | Gastroduodenal Ulcer

Korea, Republic of
National Cheng-Kung University Hospital
National Science Council, Taiwan

Completed

The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers (CSE)

Peptic Ulcer Hemorrhage

Taiwan
Chang Gung Memorial Hospital

Completed

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

Helicobacter Pylori Infection

Taiwan
GlaxoSmithKline

Terminated

Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis

Colitis, Ulcerative

United States, Netherlands, Ukraine, Estonia, Poland, France, Japan, Russian Federation, Slovakia, South Africa, United Kingdom, India, Bulgaria, Czechia, Serbia
Eli Lilly and Company
Quotient Sciences

Completed

A Multiple Dose Study of LY3502970 in Healthy Participants

Healthy

United Kingdom
Bayer

Completed

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Hot Flashes | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Netherlands
Hsiu-Chi Cheng

Completed

Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients (Eso_1y_R6PUB)

Peptic Ulcer Hemorrhage

Taiwan
Xijing Hospital of Digestive Diseases

Completed

Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy

Gastritis | Dyspepsia | Peptic Ulcer

China
Holy Stone Healthcare Co., Ltd
inVentiv Health Clinical

Completed

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Colitis, Ulcerative

Italy
Shanghai Jiao Tong University School of Medicine

Completed

High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

Helicobacter Pylori Infection

China
Ironwood Pharmaceuticals, Inc.

Terminated

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

Canada, United States
Ironwood Pharmaceuticals, Inc.

Completed

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

United States, Canada

3

Subscribe